abstract |
The present invention relates to an isolated prom-1 peptide derived from a prominin-, a conservative amino acid substitution variant of said prominin-1 peptide, or a fragment of 5 said prominin-1 peptide, as well as to isolated Platelet Rich Plasma (PRP), or a combination of PRP and said prominin-1 peptide for use in the treatment and/or prevention of lymphedema, lymphatic fistula, lymphorrea or lymphocele/seroma formation, any chronic wound not healing because of lymphorrhea or lymph secretions in surgical wounds. |